New lupus drug shows promise in early trial
NCT ID NCT02472795
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 27 times
Summary
This study tested a new drug called cenerimod in 105 people with systemic lupus erythematosus (SLE), an autoimmune disease. The goal was to see if the drug could safely lower certain immune cells (lymphocytes) in the blood, which may help control the disease. Participants continued their usual lupus medications during the trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigator Site
Anniston, Alabama, 36207, United States
-
Investigator Site
Clearwater, Florida, 33765, United States
-
Investigator Site
Minsk, 220116, Belarus
-
Investigator Site
Minsk, 223041, Belarus
-
Investigator Site
Vitebsk, 210037, Belarus
-
Investigator Site
Plovdiv, 4000, Bulgaria
-
Investigator Site
Plovdiv, 4002, Bulgaria
-
Investigator Site
Sofia, 1612, Bulgaria
-
Investigator Site
Tbilisi, 0186, Georgia
-
Investigator Site
Kemerovo, 650066, Russia
-
Investigator Site
Kursk, 305007, Russia
-
Investigator Site
Omsk, 644111, Russia
-
Investigator Site
Orenburg, 460018, Russia
-
Investigator Site
Smolensk, 214025, Russia
-
Investigator Site
Vladimir, 600023, Russia
-
Investigator Site
Vinnytsia, 21018, Ukraine
-
Investigator Site
Vinnytsia, 21029, Ukraine
-
Investigator Site
Zaporizhia, 69600, Ukraine
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.